Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
Retinal periphlebitis is inflammation of the retinal veins, most often in the peripheral retina. The inflammation can cause sheathing around veins and can reduce normal blood flow in affected areas. In some cases, retinal ischemia and new abnormal vessel growth can follow. The condition is often linked to inflammatory or infectious disease and needs a full eye evaluation.
read more about retinal periphlebitis ...Retinal periphlebitis can occur with inflammatory disease that affects blood vessels, including sarcoidosis and Behçet disease. Association with multiple sclerosis is also described, especially when inflammation is mainly venous. Infectious causes can include tuberculosis and syphilis, depending on risk factors and region. Some cases match Eales disease, which involves peripheral retinal inflammation and ischemia. A targeted workup helps connect the eye findings to the most likely cause.
Symptoms vary based on how much inflammation and ischemia are present. Blurry vision can occur when swelling reaches the macula or when bleeding affects the visual axis. Floaters can appear when inflammation spills into the vitreous or when small hemorrhages develop. Some cases stay symptom-free and are found during a dilated exam. A sudden rise in floaters, flashing lights, or a curtain-like shadow should be treated as urgent.
Diagnosis starts with a dilated retinal exam that looks for venous sheathing, hemorrhages, and ischemic changes in the periphery. Fluorescein angiography is often used to map leakage and nonperfusion and to check for neovascularization. OCT helps evaluate macular edema when central blur is present. Lab testing is often ordered to check for inflammatory or infectious triggers suggested by the exam and medical history. Follow-up imaging tracks response after treatment changes.
Treatment targets the underlying cause and aims to reduce inflammation while preventing ischemic complications. Corticosteroids or other immune-modulating medicine can be used when an autoimmune pattern is confirmed. When an infection is identified, targeted antimicrobial therapy is needed and changes the treatment plan. If ischemia drives neovascularization, laser treatment or injections can be used to reduce bleeding risk, based on retina specialist guidance. Close follow-up is important because activity can flare and complications can develop over time.
An association has been reported, especially with venous inflammation in the peripheral retina. The finding does not diagnose multiple sclerosis by itself. A clinician may recommend medical review when symptoms or history suggest a neurologic condition. Eye imaging can help document the pattern that prompts further evaluation.
Retinal vasculitis is a broader term that includes inflammation of retinal arteries, veins, or both. Periphlebitis describes venous involvement, often in the peripheral retina. Many clinicians describe periphlebitis as a subtype of retinal vasculitis. The exact label depends on exam findings and angiography results.
Yes, lasting vision change can occur when chronic ischemia, macular edema, or bleeding damages retinal tissue. Scarring after recurrent inflammation can also affect clarity. Early detection and treatment of the underlying driver can lower long-term damage risk. Ongoing monitoring helps catch new vessel growth early.
Atlas Entry - Retinal Periphlebitis. EyeRounds.org. https://www.eyerounds.org/atlas/pages/Retinal-Periphlebitis/index.htm. Date Accessed February 4, 2026.
Intermediate Uveitis. EyeWiki. https://eyewiki.org/Intermediate_Uveitis. Date Accessed February 4, 2026.
Retinal Vasculitis. EyeWiki. https://eyewiki.org/Retinal_Vasculitis. Date Accessed February 4, 2026.
Retinal periphlebitis is associated with multiple sclerosis severity. PubMed. https://pubmed.ncbi.nlm.nih.gov/23902700/. Date Accessed February 4, 2026.
Eales Disease. StatPearls (NCBI Bookshelf). https://www.ncbi.nlm.nih.gov/books/NBK559121/. Date Accessed February 4, 2026.